Prognostic role of genetic variants in recurrent pericarditis
Authors:
Open Access
- 16 July 2025
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 439, 133621
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Duration of Disease and Long‐Term Outcomes in Patients With Difficult‐To‐Treat Recurrent Pericarditis: A Chronic Condition Treated With Nonsteroidal Anti‐Inflammatory Drugs, Colchicine, Corticosteroids, and Anti–Interleukin‐1 AgentsACR Open Rheumatology, 2025
- Variants at the Interleukin 1 Gene Locus and PericarditisJAMA Cardiology, 2024
- Recurrent PericarditisJACC, 2023
- Treatment of Idiopathic Recurrent Pericarditis With GoflikiceptJACC, 2023
- Prognostic Value of Inflammatory Markers in Idiopathic Recurrent PericarditisJACC, 2022
- The Role of NLRP3 Inflammasome in PericarditisJACC: Basic To Translational Science, 2021
- Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent PericarditisNew England Journal of Medicine, 2021
- Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular DiseaseCirculation Research, 2020
- Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid DependenceJAMA, 2016
- 2015 ESC Guidelines for the diagnosis and management of pericardial diseasesEuropean Heart Journal, 2015